EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation

Michal Dubovicky, Kristína Belovicova, Kristína Csatlosova, Eszter Bogi

Interdisciplinary Toxicology · 01.09.2017 · 10 (1) · 30-34

DOI: 10.1515/intox-2017-0004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Interdisciplinary Toxicology, online erschienen am 14.02.2018. Verfasst von Michal Dubovicky und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At present, affective disorders are among the most commonly diagnosed mental diseases. In pregnancy, they can occur as pre-delivery depression, recurrent depressive disorder or postnatal depression. The estimated prevalence of depressive disorders in pregnancy is approximately 9–16%, with some statistics reporting up to 20%. Approximately 2–3% of pregnant women take antidepressants during pregnancy, and the number of mothers treated increases by birth to 5–7%. Treatment of depression during pregnancy and breastfeeding is a controversial issue, as antidepressants can negatively affect the developing fetus. According to epidemiological studies, the effects of treated depression in pregnancy are related to premature birth, decreased body weight of the child, intrauterine growth retardation, neonatal adaptive syndrome, and persistent pulmonary hypertension. However, untreated depression can adversely affect maternal health and increase the risk of preeclampsia and eclampsia, as well as of subsequent postnatal depression, which can lead to disruption of the mother-child relationship. Based on the above mentioned facts, the basic question arises as to whether or not to treat depression during pregnancy and lactation.

Schlagwörter

Stichwörter der Autor:innen

antidepressantsbehavioral disordersbraindepressionfetuslactationpregnancy

Autor:innen und Institutionen

  • Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic.

Zitieren

APA

Dubovicky, M., Belovicova, K., Csatlosova, K., & Bogi, E. (2017). Risks of using SSRI / SNRI antidepressants during pregnancy and lactation. Interdisciplinary Toxicology, 10(1), 30-34. https://doi.org/10.1515/intox-2017-0004

Vancouver

Dubovicky M, Belovicova K, Csatlosova K, Bogi E. Risks of using SSRI / SNRI antidepressants during pregnancy and lactation. Interdisciplinary Toxicology. 2017;10(1):30-34. doi:10.1515/intox-2017-0004

BibTeX
@article{Dubovicky2017,
  author = {Dubovicky, Michal and Belovicova, Kristína and Csatlosova, Kristína and Bogi, Eszter},
  title = {Risks of using SSRI / SNRI antidepressants during pregnancy and lactation},
  journal = {Interdisciplinary Toxicology},
  year = {2017},
  volume = {10},
  number = {1},
  pages = {30--34},
  doi = {10.1515/intox-2017-0004}
}
Kostenlos starten →